|
|
Clinical effect of Montelukast combined with Budesonide in the treatment of secretory otitis media |
ZHANG Cheng |
Department of Otolaryngology,Hu′nan Aerospace Hospital,Hu′nan Province,Changsha 410205,China |
|
|
Abstract Objective To explore the clinical effect of Montelukast combined with Budesonide in the treatment of secretory otitis media.Methods A total of 142 patients with secretory otitis media treated in Hu′nan Aerospace Hospital from January 2018 to January 2021 were selected,and they were divided into the control group(71 cases)and the observation group(71 cases)according to the random number table method.The patients in the two groups were given routine treatment,the patients in the control group were treated with Budesonide,and the patients in the observation group were treated with Montelukast on the basis of the control group.The clinical efficacy,tympanic pressure,speech frequency and air conduction hearing threshold of the two groups were observed,and the levels of serum paraoxonase-1(PON1),lipid hydroperoxide(LOOH)and transforming growth factor-β1(TGF-β1),transforming growth factor-β2(TGF-β2),serum interleukin-1β(IL-1β),interleukin-8(IL-8),procalcitonin(PCT)and tumor necrosis factor-α(TNF-α)were compared between the two groups.Results The total effective rate of the observation group was higher than that of the control group,and the recurrence rate of the observation group was lower than that of the control group,the differences were statistically significant(P<0.05).The tympanic pressure and speech frequency air conduction hearing threshold after treatment of the observation group were lower than those of the control group,the differences were statistically significant(P<0.05).The level of PON1 after treatment of the observation group was higher than that of the control group,and the level of LOOH after treatment of the observation group was lower than that of the control group,the differences were statistically significant(P<0.05).The levels of TGF-β1 and TGF-β2 after treatment in the observation group were lower than those in the control group,the differences were statistically significant(P<0.05).The levels of IL-1β,IL-8,PCT and TNF-α after treatment in the observation group were lower than those in the control group,the differences were statistically significant(P<0.05).Conclusion Montelukast combined with Budesonide in the treatment of secretory otitis media can effectively improve its curative effect,reduce the recurrence rate,improve the symptoms and signs of patients,increase the level of serum PON1 and reduce the level of LOOH,TGF-β1 and TGF-β2,the clinical effect is good,and it is worthy of popularization and application.
|
Received: 20 October 2021
|
|
|
|
[1] |
李献清,欧阳顺林.老年患者单耳分泌性中耳炎的临床特征和复发影响因素分析[J].重庆医学,2019,48(24):4183-4186.
|
[2] |
刘娅,孙建军.儿童分泌性中耳炎多国指南研读与解析[J].临床耳鼻咽喉头颈外科杂志,2020,34(12):1065-1069.
|
[3] |
白育青,李军,李墩,等.临床治疗分泌性中耳炎47 例疗效分析[J].中国药物与临床,2019,19(3):407-408.
|
[4] |
刘义平.氨溴索在分泌性中耳炎中的临床疗效及对血清、耳积液炎性介质的影响[J].海南医学院学报,2014,20(8):1135-1137.
|
[5] |
刘娅,李磊,于浩然,等.临床实践指南:分泌性中耳炎(更新版)[J].听力学及言语疾病杂志,2016,24(5):499-519.
|
[6] |
刘光华.曲安奈德鼓室灌注治疗分泌性中耳炎的临床研究[J].中华全科医学,2018,16(7):1104-1106.
|
[7] |
金铭鑫,张镭,申琪,等.胆脂瘤型中耳炎患者血清中对氧磷酯酶1 和脂氢过氧化物的表达及意义[J].广东医学,2020,41(21):2177-2181.
|
[8] |
蔡彬林,瞿秀,瞿春林,等.分泌性中耳炎患者关于促炎作用,液体平衡,血管通透性及氧化应激的变化分析[J].海南医学院学报,2019,25(10):788-791.
|
[9] |
杨晓琦.氨溴索在分泌性中耳炎中的临床疗效及对血清、耳积液炎性介质的影响观察[J].蚌埠医学院学报,2016,41(1):76-78.
|
[10] |
李姝娜,黄玉宇,陈向平,等.儿童分泌性中耳炎前庭功能检测研究[J].临床耳鼻咽喉头颈外科杂志,2020,34(3):202-206.
|
[11] |
闫迪,郝昌军,沈静,等.鼓膜穿刺鼓室加压吸引对分泌性中耳炎的治疗效果[J].临床和实验医学杂志,2020,19(1):111-113.
|
[12] |
赵然师,青浩渺,钟时勋,等.鼓膜置管与穿刺对鼻咽癌放疗后分泌性中耳炎疗效Meta分析[J].中华耳科学杂志,2020,18(3):443-448.
|
[13] |
Lapointe F,Turcotte S,Véronneau S,et al.Role of protein tyrosine phosphatase epsilon(PTPε)in leukotriene D4-induced CXCL8 expression[J].J Pharmacol Exp Ther,2019,369(2):270-281.
|
[14] |
Xue DX,Ye LT,Zheng J,et al.Structure based traceless specific fluorescence labeling of smoothened receptor[J].Org Biomol Chem,2019,17(25):6136-6142.
|
[15] |
Xotlanihua-Gervacio M,Herrera-Moreno JF,Medina-Díaz IM,et al.Relationship between internal and external factors and the activity of PON1[J].Environ Sci Pollut Res Int,2019,26(24):24946-24957.
|
[16] |
Ahn MS,Eom YW,Oh JE,et al.Transient receptor potential channel TRPV4 mediates TGF-β1-induced differentiation of human ventricular fibroblasts[J].Cardiol J,2020,27(2):162-170.
|
[17] |
Du YP,Sun JJ,Liu XN,et al.TGF-β2antagonizes IL-6 promoted cell survival[J].Mol Cell Biochem,2019,461(12):119-126.
|
[18] |
余巧,盛宏申,郭晓静,等.分泌性中耳炎患者外周血Th1、Th2 细胞及T 淋巴细胞亚群水平的表达及临床意义[J].现代生物医学进展,2019,19(6):1103-1107.
|
|
|
|